Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07206446) titled 'A Prospective Evaluation of a Prescription Digital Therapeutic for Treatment of Overactive Bladder in Women: The RiSolve Trial' on Sept. 26.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: University of Galway
Condition:
Overactive Bladder (OAB)
Over Active Bladder
Intervention:
Device: RiSolve
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: September 29, 2025
Target Sample Size: 45
To know more, visit https://clinicaltrials.gov/study/NCT07206446
Publi...